Purpose: Our study expands on the safety and effectiveness of BAE in lung lesions with low
flow arterio-venous shunting/bronchial-pulmonary shunting.
Materials and Methods: 55 hemoptysis patients (35 males) underwent BAE between 2018 and 2023. Mean age 54 ± 2
years. Selective catheterization of the pathologically hypertrophied bronchial artery
revealed early slow filling of the pulmonary vein denoting associated AV shunting
through the bed of the lesions. Bronchial artery was embolized successfully with 500–900
µm PVA particles.
Results: Technical success was 100%. Mean follow up period was 180 days. 3 patients developed
rebleeding and underwent another session of embolization. 15 subjects were lost to
follow-up.
Conclusion: BAE with large particles is safe in lesions with low flow bronchopulmonary shunts
with high technical and clinical success rate and no major complications.